<p>1. Understanding Tobacco Use in Different Countries<br>2. Maternal Smoking and Fetal Brain Outcome: Mechanisms and Possible Solutions<br>3. Nicotine Effects in Adolescents<br>4. The Impact of Traditional Cigarettes and ECigarettes on the Brain<br>5. Reduction of Nicotine in Tobacco and Impact<br>6. Prenatal Nicotine Exposure and Neuronal Progenitor Cells<br>7. Synaptically Located Nicotinic Acetylcholine Receptor Subunits in Neurons Involved in Dependency to Nicotine<br>8. Cotinine as a Possible Allosteric Modulator of Nicotine Effects in Various Models<br>9. Nicotine, Neural Plasticity, and Nicotine’s Therapeutic Potential<br>10. Habenular Synapses and Nicotine<br>11. Nicotine Neuroprotection of Brain Neurons: The Other Side of Nicotine Addiction<br>12. Linking Nicotine, Menthol, and Brain Changes<br>13. Cigarette Smoking and Nicotine: Effects on Multiple Sclerosis<br>14. Tobacco and Positron-Emission Tomography (PET) of the Dopaminergic System: A Review of Human Studies<br>15. Resting-State Functional Connectivity Imaging and Nicotine Dependence<br>16. Functional Magnetic Resonance Imaging of Acute Nicotine Effects<br>17. Nicotine Dependence in Schizophrenia: Contributions of Nicotinic Acetylcholine Receptors<br>18. Attentional Bias and Smoking<br>19. Effects of Nicotine on Inhibitory Control in Humans<br>20. Nicotine, Corticotropin-Releasing Factor, and Anxiety-Like Behavior<br>21. 6-Hydroxy-L-Nicotine and Memory Impairment<br>22. Cotinine and Memory: Remembering to Forget<br>23. Nicotine in Aberrant Learning and Corticostriatal Plasticity<br>24. Prenatal Nicotine Exposure and Impact on the Behaviors of Offspring<br>25. Craving in Substance Use Disorders With a Focus on Cigarette Smoking<br>26. The Acute Effect of Exercise on Cravings and Withdrawal Symptoms<br>27. CRF2 Receptor Agonists and Nicotine Withdrawal<br>28. Delirium and Nicotine Withdrawal<br>29. Postoperative Nicotine Withdrawal<br>30. Nicotine and Alpha3beta2 Neuronal Nicotinic Acetylcholine Receptors<br>31. Nicotine Addiction and Alpha4beta2* Nicotinic Acetylcholine Receptors<br>32. The Medial Habenula-Interpeduncular Nucleus Pathway in Nicotine Sensitization: The Role of α3β4 Nicotinic<br>Acetylcholine Receptors and Substance P<br>33. Targeting Nicotinic Acetylcholine Receptors for the Treatment of Pain<br>34. Pharmacology of Muscle-Type Nicotinic Receptors<br>35. Involvement of Opioid Receptors in Nicotine-Related Reinforcement and Pleasure<br>36. Nicotine-Induced Kindling: Influences of Age, Sex, and Prevention by Antioxidants<br>37. Nicotine Reward and Abstinence: Role of the CB1 Receptors<br>38. The Therapeutic Potential of the Cognitive- Enhancing Effects of Nicotine and Other Nicotinic Acetylcholine Receptor Agonists<br>39. Nicotine and Dopamine DA1 Receptor Pharmacology<br>40. Brain Gene Expression in the Context of Nicotine Rewards: A Focus on Cholinergic Genes<br>41. HIV-Infected Subjects and Tobacco Smoking: A Focus on Nicotine Effects in the Brain<br>42. Renin-Angiotensin System Genes and Nicotine Dependence<br>43. Nicotine Dependence and the CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome<br>44. Brain, Nrf2, and Tobacco: Mechanisms and Countermechanisms Underlying Oxidative-Stress-Mediated Cerebrovascular Effects of Cigarette Smoking<br>45. Effects of Nicotine and Histone Deacetylase Inhibitors on the Brain<br>46. L-Type Calcium Channels and Nicotine<br>47. The Co-occurrence of Nicotine With Other Substance Use and Addiction: Risks, Mechanisms, onsequences, and Implications for Practice,With a Focus on Youth<br>48. Comorbid Smoking and Gambling Disorder: Potential Underlying Mechanisms and Future Explorations<br>49. Neuroscience of Tobacco and Crack Cocaine Use: Metabolism, Effects, and Symptomatology<br>50. Salivary Cotinine Assays<br>51. Overview of Cotinine Cutoff Values for Smoking Status Classification<br>52. Smoking Abstinence Expectancies Questionnaire<br>53. Pharmacist-led Smoking Cessation Services: Current and Future Perspectives<br>54. Nicotine Use and Weight Control in Young People: Implications for Prevention and Early Intervention<br>55. Exercise as a Smoking Cessation Aid<br>56. Varenicline: Treating Smoking Addiction and Schizophrenia<br>57. Nicotine Vaccines: The Past, the Present, and the Future<br>58. Treating Nicotine Dependence in Psychiatric Hospitals<br>59. Oral 18-Methoxycoronaridine (18-MC) Decreases Nicotine Self-Administration in Rats <br>60. Pharmacogenetics and Smoking Cessation<br>61. The Orexin System and Nicotine Addiction: Preclinical Insights<br>62. Tobacco Control Policies and Smokers’ Responses<br>63. Resources for the Neuroscience of Nicotine</p>